Healthcare finance — bridging in context
Healthcare finance — bridging is a bridging facility secured on a first or second charge over property, sometimes across more than one asset. It is used where lenders underwrite the operator and the regulatory rating alongside the property, because value depends on the ability to keep trading.
Structurally, the facility is secured on a first or second charge over property, sometimes across more than one asset, written over terms of three to twenty-four months, with interest usually retained or rolled up, with advances commonly up to 70% to 75% of value, or a percentage of purchase price where the asset is bought below market value. Lenders assess the exit before the entry: the facility is repaid from a specific event — a sale, a refinance onto term debt, or receipt of expected funds. That ordering explains why two applicants with identical income can receive materially different terms — the credit question is whether the repayment route survives a slower market, not whether the borrower looks creditworthy today.
Activity in this segment comes from specialist care and medical lenders, challenger banks funding registered operators, non-bank lenders supporting turnaround and first-time operators and clearing bank healthcare desks. Each prices the same healthcare finance case against its own funding cost and risk appetite, which is why the same healthcare finance — bridging case can attract offers several percentage points apart. The Financial Conduct Authority supervision shapes conduct standards and, where the borrowing is regulated, the advice and disclosure obligations that sit around the transaction.
Risk factors in healthcare finance — bridging
The principal risks in healthcare finance — bridging are staffing cost inflation compressing operating margin, occupancy falling below the level the facility was sized against, goodwill value proving harder to realise than bricks and mortar and a downgraded regulatory rating affecting both value and lender appetite. None of these are unusual. All of them are manageable when they are priced at the outset rather than discovered mid-transaction.
The most common failure mode is an exit that slips. The facility is repaid from a specific event — a sale, a refinance onto term debt, or receipt of expected funds If that route depends on a sale or a refinance, a slower market extends the term, and extension terms are rarely as favourable as the original facility. Building contingency into the timetable is materially cheaper than negotiating it under pressure.
Independent valuation advice, early legal instruction, and a written repayment plan reviewed against a downside case address most of the exposure. Where borrowing is regulated, The Financial Conduct Authority conduct rules require suitability to be assessed and disclosed; where it is not, that discipline remains good practice rather than an obligation.
What lenders assess on a bridging facility
| Requirement | Typical position |
|---|---|
| Security | A first or second charge over property, sometimes across more than one asset |
| Pricing basis | A monthly interest rate rather than an annual one, plus arrangement and, on some facilities, exit fees |
| Affordability test | The credibility of the exit rather than monthly affordability, because interest is typically not serviced from income |
Common use cases for healthcare finance — bridging
Healthcare finance — bridging is most commonly used where an existing home is extended to add registered beds, specialist equipment is funded alongside the property and a care home is purchased by an experienced operator. What these situations share is a mismatch between the timing of a cost and the timing of the funds that will meet it; the facility exists to bridge that mismatch at a known price rather than to fund an indefinite shortfall.
A second group of cases is structural rather than urgent: a dental or medical practice is acquired or bought into. Here the borrower is choosing how to hold an asset over time, and the analysis is closer to a capital-structure decision than a funding emergency. Term, covenant flexibility, and early-repayment terms matter more than speed.
The route is a poor fit where the repayment plan depends on an event outside the borrower's control, or where the requirement is better met by asset finance for the clinical equipment element alone. In those cases the honest answer is that healthcare finance — bridging would refinance a problem instead of resolving it, and the deciding test is whether the facility is repaid from a specific event — a sale, a refinance onto term debt, or receipt of expected funds still holds if the timetable slips by a quarter.
From enquiry to drawdown
An application moves through four stages: an initial assessment of security and requirement, a terms sheet or decision in principle, valuation and legal due diligence, then formal offer and drawdown. Cases regularly complete in two to four weeks, and in a matter of days where title is clean and solicitors are instructed early. The valuation and legal stage accounts for most of the elapsed time and is where avoidable delays occur.
Preparation shortens the timetable more than lender selection does. Having three years of accounts with EBITDARM adjustments, the current regulatory inspection report and rating and occupancy and fee-rate history by bed or chair ready at enquiry allows a lender to issue terms on evidence rather than assumption, and reduces the number of conditions attached to the offer. Instructing solicitors experienced in healthcare finance at the same time prevents the legal work starting from a standing position after the offer arrives.
Conditions precedent are normal and usually procedural: confirmation of insurance, satisfactory searches over a first or second charge over property, sometimes across more than one asset, and evidence of the deposit or contribution. Treating them as a checklist to clear in parallel, rather than in sequence, is the practical difference between a transaction that completes on time and one that requires an extension.
Bridging facility at a glance
Typical term
Terms of three to twenty-four months, with interest usually retained or rolled up
Typical advance
Advances commonly up to 70% to 75% of value, or a percentage of purchase price where the asset is bought below market value
How it is repaid
The facility is repaid from a specific event — a sale, a refinance onto term debt, or receipt of expected funds
Supervision
The Financial Conduct Authority
How healthcare finance — bridging is priced
Pricing is built rather than quoted. The headline rate reflects a monthly interest rate rather than an annual one, plus arrangement and, on some facilities, exit fees, and the effective cost only becomes visible once arrangement fees, valuation and legal costs, and any exit or early-repayment charge are added to the same calculation. Comparing two offers on rate alone routinely selects the more expensive facility.
Three variables move the price materially: where the request sits against advances commonly up to 70% to 75% of value, or a percentage of purchase price where the asset is bought below market value, how the credibility of the exit rather than monthly affordability, because interest is typically not serviced from income is evidenced, and the time the lender is exposed before the facility is repaid from a specific event — a sale, a refinance onto term debt, or receipt of expected funds. Reducing the advance is usually the most efficient lever, because it lowers loss-given-default for the lender and therefore the margin charged. Figures discussed at enquiry stage are indicative and subject to valuation and full underwriting.
Borrowers should also price the cost of delay. Cases regularly complete in two to four weeks, and in a matter of days where title is clean and solicitors are instructed early. Where a transaction has a fixed deadline, a slightly higher margin from a lender that can meet the date is frequently cheaper than a lower margin that misses it and forfeits a deposit or a negotiated purchase price.
Who qualifies for healthcare finance — bridging
Eligibility for healthcare finance — bridging is assessed on the asset first and the applicant second. Lenders test the credibility of the exit rather than monthly affordability, because interest is typically not serviced from income, then satisfy themselves that the facility is repaid from a specific event — a sale, a refinance onto term debt, or receipt of expected funds remains achievable under stressed assumptions. Trading history, sector, and the quality of the security all move the answer, and a marginal case is far more often declined on evidence gaps than on the underlying numbers.
A complete submission normally contains staffing rotas with agency spend analysis, registration certificates for the operator and the registered manager, three years of accounts with EBITDARM adjustments and the current regulatory inspection report and rating. Where any of these are missing, underwriters price the uncertainty rather than ignore it, so incomplete packs tend to return higher rates or lower advances rather than an outright refusal. Preparing the pack before approaching lenders is the single most effective way to protect the terms available.
Where the pack is thinner, underwriters ask for occupancy and fee-rate history by bed or chair before they will commit, because those items evidence the part of the case the security cannot. Adverse credit or a short trading history moves the case towards challenger banks funding registered operators and non-bank lenders supporting turnaround and first-time operators, where criteria are set case by case. The trade-off is cost: flexibility on criteria is almost always paid for in margin, fees, or a lower advance against value.
Late payment can cause you serious money problems. For help, go to moneyhelper.org.uk.